Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities known to increase heart disease risk by two-fold and type 2 diabetes risk by five-fold. These disturbances include dyslipidemias, hypertension, hyperglycemia and central adiposity in addition to insulin resistance and low grade inflammation. The prevalence of MetS is about 34% in the United States with variations according to ethnicity and race. Lfestyle factors including smoking, lack of exercise, poor dietary habits as well as low socioeconomic status are associated with the development of MetS. Diet is considered one of the major contributors to MetS. Adherence to the Mediterranean diet (high intake of whole grains, fruits and vegetables, olive oil, fish, low-fat dairy products, and moderate wine consumption) has been associated with lower prevalence of MetS. Interventions utilizing this dietary approach have proven to be successful in reducing some of the associated metabolic abnormalities. In this review, evidence from epidemiological and clinical studies showing the benefits of the Mediterranean diet is presented. The effect of the specific components of the Mediterranean diet is also discussed.
Introduction
Overweight and obesity trends have substantially increased in alarming proportions in the last 40 years. Using the 1976-2008 National Health Interview Services, Singh et al. [i] reported that the prevalence of overall overweight increased from 36.9 to 62%, among which the prevalence of obesity increased from 8.7 to 27.4%. As it is well established that overweight/obese individuals have a higher risk of developing insulin resistance, metabolic syndrome (MetS), diabetes, hypertension and coronary heart disease (CHD) [ii] , there is a great need for prevention programs prescribing healthy diets and promoting exercise.
MetS encompasses a cluster of symptoms including dyslipidemias, central obesity, high fasting glucose and hypertension. These factors are associated with increased risk for both type-2 diabetes mellitus (T2DM) and CHD [iii] . The latest consensus on the definition of the MetS is as follows: Waist circumference (WC) ≥102 cm for men and ≥ 88 cm for women; triglycerides (TG) ≥ 150 mg/dL (1.69 mmol/L); HDL ≤ 40 mg/dL (1.04 mmol/L) for men and ≤ 50 mg/dL (1.29 mmol/L) for women; blood pressure ≥ 130/85 mm Hg; and fasting glucose ≥ 100 mg/dL (5.55 mmol/L). When 3 out of 5 identified characteristics are present, a diagnosis of MetS is made [iv] .
Central obesity or increased WC is a key determinant in the development of MetS. While abdominal obesity is determined by accumulation of both subcutaneous and visceral adipose tissue, the latter appears to play a major role in the metabolic irregularities that characterize MetS [v] . Insulin resistance and many of its related features could arise from trunk fat delivering free fatty acids (FFA) at a high rate to the liver via the portal vein. This effect in turn increases hepatic glucose production, reduces hepatic insulin clearance, and finally leads to insulin resistance, hyperinsulinemia and hyperglycemia [vi] . MetS is also characterized by a proinflammatory state and oxidative stress, which further increases CHD risk [vii] . Proinflammatory cytokines, such as C-reactive protein, interleukin (IL)-6 and tumor necrosis factoralpha (TNF-α), can also promote insulin resistance and impaired glucose tolerance, and accelerate the development of MetS and T2DM [viii] .
Changes in macronutrient composition such as carbohydrate restriction [ix] have been shown to substantially decrease central adiposity in subjects with MetS. Other dietary interventions using low glycemic-load diets [x] or low-fat diets [xi] have also been effective in reducing WC and central adiposity. Diets high in antioxidants including polyphenols [xii], carotenoids [xiii] and minerals such as selenium [xiv] have been useful in reducing inflammation and oxidative stress. Results from these studies [9] [10] [11] [12] [13] [14] indicate that both macronutrient composition and antioxidants present in food are quite effective in reducing the metabolic abnormalities that are associated with MetS.
The Mediterranean-style dietary pattern, characterized by increased consumption of whole grains, fruit, vegetables, nuts, N-3 fatty acids and olive oil, has been shown to protect against MetS [xv] . In this review, evidence from epidemiological and clinical studies showing the benefits of the Mediterranean diet (MedD) is presented. The effect of the specific components of the MedD is also discussed.
Epidemiological data
Epidemiological analyses of association between adherence to the MedD and prevalence of MetS have been conducted in different populations. Evaluation of the SUN cohort, consisting of graduate students from Universidad de Navarra who were followed for 6 A cross-sectional study from individuals participating in the Canarian Nutrition Survey (ENCA) demonstrated that highest adherence to MedD was associated with lower blood pressure, although there was also a higher prevalence of hyperglycemia [xix] . Other reported associations between dietary patterns and risk variables included moderate alcohol intake and high HDL in men, fruit intake protecting against hypertriglyceridemia, and dairy product consumption inversely associated with hyperglycemia [19] . In contrast, a multicenter study of the Mediterranean group concluded that prevalence of MetS was not related to MedD [xx] . Overall, results from the ENCA study are controversial and do not present a clear benefit of high adherence to MedD in lowering prevalence of MetS. The ATTICA study, a national health survey based on 2282 Greek adults, reported that 19.8% of subjects had MetS [xxi] . Although the odds ratio of having MetS among individuals consuming the MedD was 0.81, high levels of inflammatory markers in this population could not be explained by the choice of diet [xxi].
Rumawas et al.
[xv] evaluated the effects of MedD pattern in mitigating the risk factors for T2DM and CHD in the Framingham offspring cohort. Higher adherence to this diet was associated with lower WC, fasting plasma glucose, TG, and high HDL, indicating that this type of diet modifies all parameters of MetS. Further, the consumption of the MedD has been evaluated in patients diagnosed with heart disease [xxii], those with T2DM [xxiii], and those receiving renal transplantation [xxiv] . In these three studies, adherence to the MedD has been associated with reduced risk of MetS.
Clinical trials Effects on parameters of MetS
Several recent clinical trials demonstrated that following a MedD resulted in the improvement of one or more characteristics of MetS. Esposito et al.
[xxv] compared two different interventions, a MedD (n = 90) and a prudent diet (n = 90). After 2 years, 40 patients in the intervention group had MetS compared to 78 in the control group (P < 0.001), indicating a greater net resolution of MetS when consuming MedD. Lerman et al.
[xxvi] recruited 49 subjects with MetS and hypercholesterolemia who were prescribed to consume a low-glycemic-load Mediterranean style diet for 12 weeks. Subjects were randomized to diet alone or diet supplemented with specific phytochemicals. At end of study, 22% of subjects consuming the diet alone and 43% of those receiving the additional phytochemicals had a net resolution of MetS, and the latter had greater reductions in their dyslipidemias. Estruch et al [xxvii] recruited 72 individuals and assigned them to 3 different groups: low-fat diet (n=257), MedD plus olive oil (n= 257), or MedD plus nuts (n=258). The authors concluded that the MedD was more effective than the low-fat diet in reducing the parameters associated with MetS and inflammation. In the PREDIMED randomized trial of high risk individuals, researchers reported that enriching the MedD with nuts was more effective in reducing abdominal obesity, decreasing plasma TG and improving blood pressure [xxviii] .
Other studies have also reported improvement on all MetS parameters after following a MedD for 12 weeks [xxix]. In contrast, in a study of individuals with already established and treated CHD who adopted a MedD over 1 year, the diet had no effect on markers of inflammation or other metabolic risk factors [xxx] . In another study in which subjects with abdominal obesity were prescribed a MedD for 2 months [xxxi], those under diet supervision (to ensure adherence to MedD) exhibited improved endothelial function and greater reductions in blood pressure [xxxi] .
Effects on inflammatory markers
In a study of 220 healthy women from Greece, significant associations were found between the adiponectin levels and the consumption of whole grain, low-fat dairy, and reduced intake of refined cereals, three components of the MedD [32] . Hermsdorff et al.
[xxxii] evaluated the effects of a hypocaloric MedD diet on plasma concentrations of retinol binding protein-4 (RBP4), TNF-α and IL-6. Individuals who had greater adherence to the diet exhibited significant reductions in these markers of inflammation. A study using a MedD with a low glycemic load also demonstrated a reduction in inflammation and insulin resistance after 12 weeks [xxxiii]. Overall, these results suggest the efficacy of MedD in healthy populations [25] [26] [27] [28] [29] [31] [32] [33] [34] . A summary of these studies is presented in Table 1 . 
Individual components of MedD and their effects on parameters of MetS
The multiple beneficial effects of the MedD on the parameters of MetS are closely associated with its individual dietary components. The effects of these components on WC, BP, TG, HDL and fasting glucose are summarized in Figure 1 . Figure 1 . Effects of the Mediterranean diet on the parameters of metabolic syndrome (MetS). Central obesity is on the axis of MetS leading to increased waist circumference (1. WC). Free fatty acids (FFA) are released into circulation from adipose tissue to liver, muscle and pancreas. In the liver, they result in increased production of VLDL associated with elevated plasma triglycerides (2. TG) and low HDL (3. HDL). In the pancreas, there is apoptosis and cell death that will result in increases in plasma glucose (4. Glucose). In the muscle, FFA lead to insulin resistance and increased blood pressure (5. BP). In parentheses next to each of the MetS characteristics are some of the nutrients or food items from Mediterranean diet that have been shown to correct that metabolic abnormality.
N-3 fatty acids or fish consumption.
It is well established that intake of N-3 fatty acids, especially in the form of fish oil, results in decreases in plasma TG [xxxiv] . The main mechanisms involved are decreased hepatic TG synthesis and faster removal from plasma [xxxv] . Consumption of fish oil has also been associated with decreases in CHD due to its known effects in preventing arrhythmias, decreasing platelet aggregation, and lowering heart rate [xxxv]. Further, fish oil has been shown to decrease blood pressure [xxxiv] .
Olive oil. Olive oil is one of the most representative food items of the traditional MedD. A recent review demonstrated its beneficial effects on lowering blood pressure, reducing plasma glucose, and improving the cholesterol/HDL ratio and endothelial function [xxxvi] . In a study in which MetS patients consumed virgin olive oil and provided blood samples, the researchers found repressed expression of pro-inflammatory genes in the mononuclear cells [xxxvii] . This suggests that the anti-inflammatory effects associate with MedD could partially be attributed to this dietary constituent.
Low-fat dairy. Epidemiological data suggest a strong link between dairy consumption and decreased insulin resistance and incidence of T2DM. 
Conclusion
With its macronutrient composition and the presence of antioxidants, N-3 fatty acids and moderate alcohol, the Mediterranean diet appears to be effective in decreasing metabolic abnormalities associated with MetS, including central obesity, dyslipidemias, hypertension, hyperglycemia, and inflammation. Epidemiological data suggest that individuals following this type of diet are at decreased risk for MetS and the associated complications of T2DM and CHD. Further, recent clinical trials in healthy individuals and those diagnosed with heart disease, diabetes or renal failure appear to benefit from adhering to Mediterranean style diets.
